{"683589":{"#nid":"683589","#data":{"type":"news","title":"Georgia Tech Advances 500+ Technologies Toward Market for Real-World Impact ","body":[{"value":"\u003Cp\u003EGeorgia Tech has posted its strongest year ever in research commercialization, breaking multiple records for invention disclosures, issued patents, and licensed technologies \u2014 clear indicators of the Institute\u2019s expanding role in delivering research-driven innovation to the marketplace.\u003C\/p\u003E\u003Cp\u003E\u201cInvention is only the beginning. What sets Georgia Tech apart is our ability to\u202fmove our ideas out of the lab and into the marketplace, where they can make a tangible impact on human life and contribute to our economy,\u201d said \u00c1ngel Cabrera, president of Georgia Tech. \u201cThis year\u2019s record results show that our researchers aren\u2019t just pushing the boundaries of knowledge \u2014 they\u2019re\u202fcreating marketable solutions with the power to improve\u202feveryday lives.\u201d\u003C\/p\u003E\u003Cp\u003EFor fiscal year 2025, Georgia Tech reported:\u003C\/p\u003E\u003Cul\u003E\u003Cli\u003E\u003Cstrong\u003EMore than 460 new invention disclosures \u2014 a 30% increase\u003C\/strong\u003E over the previous year and the highest ever recorded by the Institute.\u003Cul\u003E\u003Cli\u003E\u003Cstrong\u003E70 invention disclosures \u003C\/strong\u003Efor the Georgia Tech Research Institute, marking a \u003Cstrong\u003E70% increase\u003C\/strong\u003E year over year.\u003C\/li\u003E\u003C\/ul\u003E\u003C\/li\u003E\u003Cli\u003EA \u003Cstrong\u003E210% increase in technologies licensed\u003C\/strong\u003E, and \u003Cstrong\u003E140% in total licenses executed\u003C\/strong\u003E, reflecting unprecedented industry interest, with \u003Cstrong\u003E65 licenses\u003C\/strong\u003E in total. \u0026nbsp;\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003E124 U.S. patents were issued\u003C\/strong\u003E, representing a \u003Cstrong\u003E20% increase\u003C\/strong\u003E compared to the prior year.\u003Cul\u003E\u003Cli\u003EAccording to the most recent rankings from the \u003Ca href=\u0022https:\/\/academyofinventors.org\/wp-content\/uploads\/2025\/04\/2024-Top-100-US-Universities.pdf\u0022\u003ENational Academy of Inventors\u003C\/a\u003E, Georgia Tech is in the \u003Cstrong\u003Etop 15 public universities\u003C\/strong\u003E for U.S. utility patents filed.\u003C\/li\u003E\u003C\/ul\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003Cp\u003EThis momentum strengthens Atlanta\u2019s position as one of the nation\u2019s fastest-growing innovation economies. Georgia Tech plays a leading role in advancing the region\u2019s ambition to become a \u003Ca href=\u0022https:\/\/news.gatech.edu\/features\/2024\/02\/making-atlanta-top-5-tech-hub\u0022\u003Etop 5 tech hub\u003C\/a\u003E by connecting world-class research with industry, supporting a thriving startup ecosystem, and fueling talent pipelines that serve emerging sectors like AI, cybersecurity, and clean energy. \u0026nbsp;\u003C\/p\u003E\u003Cp\u003EOmer Inan, a Georgia Tech researcher and faculty member, has launched multiple companies with the support of the Institute\u2019s commercialization resources. \u003Ca href=\u0022https:\/\/cardiosense.com\/\u0022\u003ECardiosense\u003C\/a\u003E is a medical AI company that leverages sensors to provide better management of cardiovascular disease. Having just achieved FDA 501(k) clearance, its latest device \u2014 CardioTag \u2014 is the first multimodal, wearable sensor that simultaneously captures three cardio signals to provide noninvasive solutions for heart health. \u0026nbsp;\u003C\/p\u003E\u003Cp\u003E\u0022The med tech research I conduct at Georgia Tech delivers new technologies to keep patients with heart failure out of the hospital and enables them to monitor their health status at home,\u201d said Inan. \u201cNow, we are commercializing the technology our lab helped develop, so that this dream of improving the quality of care and life for millions of Americans with heart failure can one day become reality.\u0022\u003C\/p\u003E\u003Cp\u003E\u201cAs we look to solidify Georgia Tech\u2019s status as a national innovation hub, we are moving research into the marketplace so it can truly make a difference in people\u2019s lives,\u201d said Raghupathy \u201cSiva\u201d Sivakumar, vice president of Commercialization and chief commercialization officer at Georgia Tech. \u201cWe are at a pivotal moment to put Atlanta on the map as a leader in research commercialization and have an opportunity to capitalize on our $1.4 billion in research expenditures that drive meaningful inventions, IP, and industry partnerships.\u201d \u0026nbsp;\u003C\/p\u003E\u003Cp\u003ETo learn more about the licensing and commercialization process at Georgia Tech, visit \u003Ca href=\u0022https:\/\/licensing.research.gatech.edu\/\u0022\u003Elicensing.research.gatech.edu\u003C\/a\u003E.\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EAvailable for Media Interviews\u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003E\u003Ca href=\u0022https:\/\/create-x.gatech.edu\/directory\/person\/raghupathy-sivakumar-phd\u0022\u003ERaghupathy \u0022Siva\u0022 Sivakumar\u0026nbsp;\u003C\/a\u003E\u003Cbr\u003EVice President of Commercialization and\u0026nbsp;\u003Cbr\u003EChief Commercialization Officer\u0026nbsp;\u003Cbr\u003EGeorgia Tech\u003C\/p\u003E\u003Cp\u003E\u003Ca href=\u0022https:\/\/ece.gatech.edu\/directory\/omer-t-inan\u0022\u003EOmer Inan\u003C\/a\u003E\u0026nbsp;\u003Cbr\u003EProfessor and Regents\u2019 Entrepreneur \u0026nbsp;\u003Cbr\u003ESchool of Electrical and Computer Engineering at Georgia Tech\u003C\/p\u003E\u003Cp\u003EMedia Contact:\u0026nbsp;\u003Cbr\u003ELauren Schiffman\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp; \u0026nbsp;\u0026nbsp;\u003Cbr\u003EPressFriendly \u0026nbsp;\u0026nbsp;\u003Cbr\u003E\u003Ca href=\u0022mailto:lauren@pressfriendly.com\u0022\u003Elauren@pressfriendly.com\u003C\/a\u003E \u0026nbsp;\u003Cbr\u003E\u003Cbr\u003EAngela Barajas Prendiville \u0026nbsp;\u0026nbsp;\u003Cbr\u003EDirector of Media Relations \u0026nbsp; \u0026nbsp;\u003Cbr\u003EGeorgia Institute of Technology \u0026nbsp;\u0026nbsp;\u003Cbr\u003E\u003Ca href=\u0022mailto:aprendiville@gatech.edu\u0022\u003Eaprendiville@gatech.edu\u003C\/a\u003E \u0026nbsp;\u003C\/p\u003E\u003Cp\u003E\u0026nbsp;\u003C\/p\u003E","summary":"","format":"limited_html"}],"field_subtitle":"","field_summary":[{"value":"\u003Cp\u003ERecord-breaking numbers from the Office of Commercialization drive meaningful inventions, IP, and industry partnerships.\u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":[{"value":"Record-breaking numbers from the Office of Commercialization drive meaningful inventions, IP, and industry partnerships."}],"uid":"28766","created_gmt":"2025-08-06 16:55:57","changed_gmt":"2025-08-12 18:27:37","author":"Shelley Wunder-Smith","boilerplate_text":"","field_publication":"","field_article_url":"","location":"Atlanta, GA","dateline":{"date":"2025-08-06T00:00:00-04:00","iso_date":"2025-08-06T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"hg_media":{"677597":{"id":"677597","type":"image","title":"Omer-Inan-lab.jpeg","body":"\u003Cp\u003ECardioTag,\u0026nbsp;a device\u0026nbsp;developed in Omer Inan\u2019s lab, is now FDA-cleared and on the path to market through Cardiosense.\u0026nbsp;Georgia Tech\u0026nbsp;supported the technology\u2019s transition from research to real-world application.\u003C\/p\u003E","created":"1754499369","gmt_created":"2025-08-06 16:56:09","changed":"1754499369","gmt_changed":"2025-08-06 16:56:09","alt":"A man with tan skin and dark hair, wearing a mint-green shirt, is seated at a table and looking at the CardioTag device.","file":{"fid":"261510","name":"Omer-Inan-lab.jpeg","image_path":"\/sites\/default\/files\/2025\/08\/06\/Omer-Inan-lab.jpeg","image_full_path":"http:\/\/hg.gatech.edu\/\/sites\/default\/files\/2025\/08\/06\/Omer-Inan-lab.jpeg","mime":"image\/jpeg","size":7222477,"path_740":"http:\/\/hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/2025\/08\/06\/Omer-Inan-lab.jpeg?itok=9avC1vJH"}}},"media_ids":["677597"],"groups":[{"id":"1188","name":"Research Horizons"}],"categories":[{"id":"138","name":"Biotechnology, Health, Bioengineering, Genetics"},{"id":"135","name":"Research"}],"keywords":[{"id":"192255","name":"go-commercializationnews"},{"id":"187915","name":"go-researchnews"},{"id":"187423","name":"go-bio"}],"core_research_areas":[{"id":"39441","name":"Bioengineering and Bioscience"},{"id":"193658","name":"Commercialization"}],"news_room_topics":[{"id":"106361","name":"Business and Economic Development"},{"id":"71881","name":"Science and Technology"}],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[],"email":[],"slides":[],"orientation":[],"userdata":""}}}